New and Revised FDA Import Alerts for Dec. 14
On Dec. 14 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
- 99-08: Processed Foods for Pesticides (here)
- 99-05: Raw Agricultural Products for Pesticides (here)
- 66-74: Dentifrice Products Containing Diethylene Glycol (DEG) (here)
- 66-72: Misbranded Drugs And Marketed New Drugs Without Approved Applications (here)
- 66-71: Human Growth Hormone (HGH), Also Known As Somatropin (here)
- 66-66: APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122 (here)
- 66-57: Foreign manufactured Unapproved Prescription Drugs Promoted to Individuals in the U.S. (here)
- 66-41: Unapproved New Drugs Promoted In The U.S. (here)
- 66-05: Foreign Labeled Finished Dosage Parenterals (here)
- 62-07: Shipments of Sygen Injectable (Bovine-Extracted GMI Monosialoganglioside) (here)
- 61-06: Skin Cap Spray, Shampoo And Cream (here)
- 60-02: Anabolic Steroid Prescription Drugs (here)
- 55-02: Bulk Ingredients Susceptible To Contamination With Diethylene Glycol (here)
- 54-13: Dietary Supplements And Bulk Dietary Ingredients Containing Ephedrine Alkaloids From All Countries (here)
- 53-06: Cosmetics Containing Illegal Colors (here)